Garmin Ltd (GRMN)vsZepp Health Corp (ZEPP)
GRMN
Garmin Ltd
$253.08
+2.13%
TECHNOLOGY · Cap: $48.43B
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Garmin Ltd generates 2699% more annual revenue ($7.25B vs $258.90M). GRMN leads profitability with a 23.0% profit margin vs -15.5%. GRMN earns a higher WallStSmart Score of 61/100 (C+).
GRMN
Buy61
out of 100
Grade: C+
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-32.3%
Fair Value
$156.19
Current Price
$253.08
$96.89 premium
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Keeps 23 of every $100 in revenue as profit
Strong operational efficiency at 28.9%
16.6% revenue growth
Earnings expanding 21.2% YoY
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Moderate valuation
Expensive relative to growth rate
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : GRMN
The strongest argument for GRMN centers on Debt/Equity, Altman Z-Score, Profit Margin. Profitability is solid with margins at 23.0% and operating margin at 28.9%. Revenue growth of 16.6% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : GRMN
The primary concerns for GRMN are P/E Ratio, PEG Ratio.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
GRMN profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
GRMN scores higher overall (61/100 vs 41/100), backed by strong 23.0% margins and 16.6% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Garmin Ltd
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
Garmin Ltd. is an American multinational technology company with headquarters in Olathe, Kansas.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SCIENTIFIC & TECHNICAL INSTRUMENTS Stocks
Want to dig deeper into these stocks?